Clinicopathological Correlates in a PRNP P102L Mutation Carrier with Rapidly Progressing Parkinsonism-Dystonia

Chizoba C. Umeh, Piyush Kalakoti, Michael K. Greenberg, Silvio Notari, Yvonne Cohen, Pierluigi Gambetti, Adrian L. Oblak, Bernardino Ghetti, Zoltan Mari

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Parkinsonism-dystonia is rare in carriers of the prion protein (PrP) gene (PRNP) proline-to-leucine substitution at codon 102 (P102L mutation). The severity and distribution of PrP deposition may influence the clinical presentation. The authors present such clinicopathological correlation in a 56-year-old man who had a PRNP P102L mutation associated with a phenotype characterized by rapidly progressing parkinsonism-dystonia. The patient was studied clinically (videotaped examinations, brain magnetic resonance images [MRIs]) and was analyzed using molecular genetics (gene sequence analysis) and neuropathology (histology, immunohistochemistry) during his 7-month disease course. The patient had parkinsonism, apraxia, aphasia, and dystonia, which progressed rapidly. Molecular genetic analysis revealed his PRNP P102L mutation carrier status. Brain MRIs revealed progressive, global volume loss and T2-weighted/fluid-attenuated inversion recovery hyperintensity in the neocortex and basal ganglia. Postmortem examination showed neuronal loss, gliosis, spongiform changes, and PrP deposition in the striatum. PrP immunohistochemistry revealed widespread, severe PrP deposition in the thalamus and cerebellar cortex. Based on the neuropathological and molecular-genetic analyses, the rapidly progressing parkinsonism-dystonia was correlated with nigrostriatal, thalamic, and cerebellar pathology.

Original languageEnglish (US)
Pages (from-to)355-358
Number of pages4
JournalMovement Disorders Clinical Practice
Volume3
Issue number4
DOIs
StatePublished - Jul 1 2016

Fingerprint

Dystonia
Parkinsonian Disorders
Mutation
Molecular Biology
Magnetic Resonance Spectroscopy
Immunohistochemistry
Apraxias
Cerebellar Cortex
Gliosis
Aphasia
Neocortex
Brain
Basal Ganglia
Thalamus
Proline
Codon
Leucine
Genes
Sequence Analysis
Autopsy

Keywords

  • dystonia
  • Gerstmann–Sträussler–Scheinker disease
  • parkinsonism
  • prion protein
  • proline-to-leucine substitution at codon 102 (P102L) mutation

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Umeh, C. C., Kalakoti, P., Greenberg, M. K., Notari, S., Cohen, Y., Gambetti, P., ... Mari, Z. (2016). Clinicopathological Correlates in a PRNP P102L Mutation Carrier with Rapidly Progressing Parkinsonism-Dystonia. Movement Disorders Clinical Practice, 3(4), 355-358. https://doi.org/10.1002/mdc3.12307

Clinicopathological Correlates in a PRNP P102L Mutation Carrier with Rapidly Progressing Parkinsonism-Dystonia. / Umeh, Chizoba C.; Kalakoti, Piyush; Greenberg, Michael K.; Notari, Silvio; Cohen, Yvonne; Gambetti, Pierluigi; Oblak, Adrian L.; Ghetti, Bernardino; Mari, Zoltan.

In: Movement Disorders Clinical Practice, Vol. 3, No. 4, 01.07.2016, p. 355-358.

Research output: Contribution to journalArticle

Umeh, CC, Kalakoti, P, Greenberg, MK, Notari, S, Cohen, Y, Gambetti, P, Oblak, AL, Ghetti, B & Mari, Z 2016, 'Clinicopathological Correlates in a PRNP P102L Mutation Carrier with Rapidly Progressing Parkinsonism-Dystonia', Movement Disorders Clinical Practice, vol. 3, no. 4, pp. 355-358. https://doi.org/10.1002/mdc3.12307
Umeh, Chizoba C. ; Kalakoti, Piyush ; Greenberg, Michael K. ; Notari, Silvio ; Cohen, Yvonne ; Gambetti, Pierluigi ; Oblak, Adrian L. ; Ghetti, Bernardino ; Mari, Zoltan. / Clinicopathological Correlates in a PRNP P102L Mutation Carrier with Rapidly Progressing Parkinsonism-Dystonia. In: Movement Disorders Clinical Practice. 2016 ; Vol. 3, No. 4. pp. 355-358.
@article{2a66dad3c5b045ddbceffed268badbe1,
title = "Clinicopathological Correlates in a PRNP P102L Mutation Carrier with Rapidly Progressing Parkinsonism-Dystonia",
abstract = "Parkinsonism-dystonia is rare in carriers of the prion protein (PrP) gene (PRNP) proline-to-leucine substitution at codon 102 (P102L mutation). The severity and distribution of PrP deposition may influence the clinical presentation. The authors present such clinicopathological correlation in a 56-year-old man who had a PRNP P102L mutation associated with a phenotype characterized by rapidly progressing parkinsonism-dystonia. The patient was studied clinically (videotaped examinations, brain magnetic resonance images [MRIs]) and was analyzed using molecular genetics (gene sequence analysis) and neuropathology (histology, immunohistochemistry) during his 7-month disease course. The patient had parkinsonism, apraxia, aphasia, and dystonia, which progressed rapidly. Molecular genetic analysis revealed his PRNP P102L mutation carrier status. Brain MRIs revealed progressive, global volume loss and T2-weighted/fluid-attenuated inversion recovery hyperintensity in the neocortex and basal ganglia. Postmortem examination showed neuronal loss, gliosis, spongiform changes, and PrP deposition in the striatum. PrP immunohistochemistry revealed widespread, severe PrP deposition in the thalamus and cerebellar cortex. Based on the neuropathological and molecular-genetic analyses, the rapidly progressing parkinsonism-dystonia was correlated with nigrostriatal, thalamic, and cerebellar pathology.",
keywords = "dystonia, Gerstmann–Str{\"a}ussler–Scheinker disease, parkinsonism, prion protein, proline-to-leucine substitution at codon 102 (P102L) mutation",
author = "Umeh, {Chizoba C.} and Piyush Kalakoti and Greenberg, {Michael K.} and Silvio Notari and Yvonne Cohen and Pierluigi Gambetti and Oblak, {Adrian L.} and Bernardino Ghetti and Zoltan Mari",
year = "2016",
month = "7",
day = "1",
doi = "10.1002/mdc3.12307",
language = "English (US)",
volume = "3",
pages = "355--358",
journal = "Movement Disorders Clinical Practice",
issn = "2330-1619",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - Clinicopathological Correlates in a PRNP P102L Mutation Carrier with Rapidly Progressing Parkinsonism-Dystonia

AU - Umeh, Chizoba C.

AU - Kalakoti, Piyush

AU - Greenberg, Michael K.

AU - Notari, Silvio

AU - Cohen, Yvonne

AU - Gambetti, Pierluigi

AU - Oblak, Adrian L.

AU - Ghetti, Bernardino

AU - Mari, Zoltan

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Parkinsonism-dystonia is rare in carriers of the prion protein (PrP) gene (PRNP) proline-to-leucine substitution at codon 102 (P102L mutation). The severity and distribution of PrP deposition may influence the clinical presentation. The authors present such clinicopathological correlation in a 56-year-old man who had a PRNP P102L mutation associated with a phenotype characterized by rapidly progressing parkinsonism-dystonia. The patient was studied clinically (videotaped examinations, brain magnetic resonance images [MRIs]) and was analyzed using molecular genetics (gene sequence analysis) and neuropathology (histology, immunohistochemistry) during his 7-month disease course. The patient had parkinsonism, apraxia, aphasia, and dystonia, which progressed rapidly. Molecular genetic analysis revealed his PRNP P102L mutation carrier status. Brain MRIs revealed progressive, global volume loss and T2-weighted/fluid-attenuated inversion recovery hyperintensity in the neocortex and basal ganglia. Postmortem examination showed neuronal loss, gliosis, spongiform changes, and PrP deposition in the striatum. PrP immunohistochemistry revealed widespread, severe PrP deposition in the thalamus and cerebellar cortex. Based on the neuropathological and molecular-genetic analyses, the rapidly progressing parkinsonism-dystonia was correlated with nigrostriatal, thalamic, and cerebellar pathology.

AB - Parkinsonism-dystonia is rare in carriers of the prion protein (PrP) gene (PRNP) proline-to-leucine substitution at codon 102 (P102L mutation). The severity and distribution of PrP deposition may influence the clinical presentation. The authors present such clinicopathological correlation in a 56-year-old man who had a PRNP P102L mutation associated with a phenotype characterized by rapidly progressing parkinsonism-dystonia. The patient was studied clinically (videotaped examinations, brain magnetic resonance images [MRIs]) and was analyzed using molecular genetics (gene sequence analysis) and neuropathology (histology, immunohistochemistry) during his 7-month disease course. The patient had parkinsonism, apraxia, aphasia, and dystonia, which progressed rapidly. Molecular genetic analysis revealed his PRNP P102L mutation carrier status. Brain MRIs revealed progressive, global volume loss and T2-weighted/fluid-attenuated inversion recovery hyperintensity in the neocortex and basal ganglia. Postmortem examination showed neuronal loss, gliosis, spongiform changes, and PrP deposition in the striatum. PrP immunohistochemistry revealed widespread, severe PrP deposition in the thalamus and cerebellar cortex. Based on the neuropathological and molecular-genetic analyses, the rapidly progressing parkinsonism-dystonia was correlated with nigrostriatal, thalamic, and cerebellar pathology.

KW - dystonia

KW - Gerstmann–Sträussler–Scheinker disease

KW - parkinsonism

KW - prion protein

KW - proline-to-leucine substitution at codon 102 (P102L) mutation

UR - http://www.scopus.com/inward/record.url?scp=85052315316&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052315316&partnerID=8YFLogxK

U2 - 10.1002/mdc3.12307

DO - 10.1002/mdc3.12307

M3 - Article

AN - SCOPUS:85052315316

VL - 3

SP - 355

EP - 358

JO - Movement Disorders Clinical Practice

JF - Movement Disorders Clinical Practice

SN - 2330-1619

IS - 4

ER -